Dr. Dalit Ashany specializes in the treatment of systemic lupus erythematosus, rheumatoid arthritis and osteoarthritis. Dr. Ashany has received numerous awards throughout her career, including the National SLE Foundation Research Grant, NIH-NIAMS Career Development Award, SLE Foundation Career Development Award, and the Merck Sharp and Dohme Arthritis Research Fellow's Award. She is currently an Assistant Attending Rheumatologist at Hospital for Special Surgery.
Assistant Attending Physician, Hospital for Special Surgery
Assistant Professor of Medicine, Weill Cornell Medical College
Systemic Lupus Erythematosus
Castle Connolly Regional Top Doctor, 2013-2020
Castle Connolly Top Doctors in New York Metro Area, 2014-2020
New York Magazine Top Doctors, 2016
National SLE Foundation Research Grant, 1998
NIH-NIAMS Career Development Award, 1996
SLE Foundation Career Development Award, 1991
Merck Sharp and Dohme Arthritis Research Fellow's Award, 1990
Alpha Omega Alpha Medical Honor Society, 1984
One of the goals of HSS is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
As of December 22, 2020, Dr. Ashany reported no relationships with healthcare industry.
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.
Ashany D, Savir A, Bhardwaj N, Elkon KB. Dendritic Cell Resistance to Fas-mediated Apoptosis. J. Immunol. Nov 15;163(10):5303-11, 1999.
Drappa J, Kamen LA, Chan E, Georgiev M, Ashany D, Marti F, King PD. Impaired T Cell Death and Lupus-like Autoimmunity in T Cell-specific Adapter Protein-deficient Mice. J Exp Med. Sep 1;198(5):809-21, 2003.
Georgierv M, Agle LMA, Chu JL, Elkon KB, Ashany D. “Mature Dendritic Cells Readily Break Tolerance in Normal Mice but Do Not Lead to Disease Expression.” Arthritis Rheum 52(1): 225-238; 2005.
For more publications, please see the PubMed listing.